DeGette, Bucshon Lead Bipartisan Push to Improve Diagnostic Testing

July 14, 2021 by TWN Staff
DeGette, Bucshon Lead Bipartisan Push to Improve Diagnostic Testing

WASHINGTON – Reps. Diana DeGette, D-Colo., and Dr. Larry Bucshon, R-Ind., are leading a renewed bipartisan drive to improve the nation’s diagnostic testing capabilities and ensure hospitals and laboratories across the country are better able to respond to future national health emergencies, such as the COVID-19 pandemic.

The legislation is known as the Verifying Accurate, Leading-edge IVCT Development, or VALID, Act. An identical version of the bill – sponsored by Sens. Michael Bennet, D-Colo., and Richard Burr, R-N.C., has been introduced in the Senate.

It would, among other things, permanently lift a Food and Drug Administration requirement that all diagnostic tests used to screen patients during a declared public health emergency be approved by the agency before they are used to diagnose the emerging threat.

Instead, under the terms of the bill, hospitals and labs that have validated their tests – and provided that data to FDA – would be able to start using them immediately to screen patients as FDA considers their application for emergency use.

The legislation also seeks to address concerns raised by public health officials in the early stages of the pandemic that the FDA policy in place at the outset of the pandemic impeded their ability to quickly and efficiently respond to the virus and, when necessary, quarantine those who had become infected.

“If we’ve learned anything from combating the spread of highly contagious viruses – such as MERS, SARS, Ebola and now COVID-19 – it’s that time is of the essence,” DeGette said. “We can’t allow an outdated and inefficient system to hold us back when trying to respond to an emerging threat, such as the coronavirus. 

“This legislation will ensure that our hospitals and laboratories have the ability to respond quickly, accurately and efficiently to help us detect and stop the spread of these diseases before it’s too late,” she said.

In addition to removing the FDA’s pre-approval requirement for tests used to screen patients during future public health emergencies, DeGette and Bucshon’s legislation would completely overhaul how the federal government reviews and approves all diagnostic tests going forward.

Among other things, it would create an entirely new product category for diagnostic and lab tests, putting their review and approval squarely under the FDA. 

It would also create a new system that would allow hospitals and labs to submit their tests to the FDA electronically, a change that would improve the agency’s ability to oversee their quality and reliability, while at the same time drastically reducing the time it takes the agency to review them.

Additionally, the VALID Act would establish a program to expedite the development and review of new diagnostic tests that seek to address a current unmet need for patients. And it includes a provision to grandfather in any tests currently available to patients in the U.S. so it doesn’t – in any way – impede the ability of health care providers to continue testing and treating patients as they are today.

Diagnostic tests are an important tool used by health care providers across the U.S. to make sometimes difficult decisions about the best course of care and treatment for their patients. The accuracy and reliability of such tests can literally mean the difference between life and death for some patients.

A+
a-
  • diagnostic testing capabilities
  • diagnostics
  • Diana Degette
  • hospitals
  • laboratories
  • Larry Bucshon
  • VALID Act
  • In The News

    Health

    Voting

    Health

    Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    Five Takeaways From the Abortion Pill Case Before US Supreme Court

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

    Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    News From The Well
    scroll top